Literature DB >> 10781091

Development of an extrachromosomal cloning vector system for use in Borrelia burgdorferi.

M Sartakova1, E Dobrikova, F C Cabello.   

Abstract

Molecular genetic analysis of Borrelia burgdorferi, the cause of Lyme disease, has been hampered by the absence of any means of efficient generation, identification, and complementation of chromosomal and plasmid null gene mutants. The similarity of borrelial G + C content to that of Gram-positive organisms suggested that a wide-host-range plasmid active in Gram-positive bacteria might also be recognized by borrelial DNA replication machinery. One such plasmid, pGK12, is able to propagate in both Gram-positive and Gram-negative bacteria and carries erythromycin and chloramphenicol resistance markers. pGK12 propagated extrachromosomally in B. burgdorferi B31 after electroporation but conferred only erythromycin resistance. pGK12 was used to express enhanced green fluorescent protein in B31 under the control of the flaB promoter. Escherichia coli transformed with pGK12 DNA extracted from B31 expressing only erythromycin resistance developed both erythromycin and chloramphenicol resistance, and plasmid DNA isolated from these transformed E. coli had a restriction pattern similar to the original pGK12. Our data indicate that the replicons of pGK12 can provide the basis to continue developing efficient genetic systems for B. burgdorferi together with the erythromycin resistance and reporter egfp genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781091      PMCID: PMC18321          DOI: 10.1073/pnas.080068797

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Oligonucleotide-mediated genetic transformation of Borrelia burgdorferi.

Authors:  D Scott Samuels; Claude F Garon
Journal:  Microbiology (Reading)       Date:  1997-02       Impact factor: 2.777

2.  Electrotransformation of the spirochete Borrelia burgdorferi.

Authors:  D S Samuels
Journal:  Methods Mol Biol       Date:  1995

3.  beta-lactam antibiotics in the treatment of neuroborreliosis in children: preliminary results.

Authors:  M M Millner; G H Thalhammer; P Dittrich; K D Spork; M Brunner; A Georgopoulos
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

4.  Analysis of promoters in Borrelia burgdorferi by use of a transiently expressed reporter gene.

Authors:  C D Sohaskey; C Arnold; A G Barbour
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

5.  Identification and mapping of a chromosomal gene cluster of Borrelia burgdorferi containing genes expressed in vivo.

Authors:  L Aron; C Toth; H P Godfrey; F C Cabello
Journal:  FEMS Microbiol Lett       Date:  1996-12-15       Impact factor: 2.742

6.  In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.

Authors:  R J Kazragis; L L Dever; J H Jorgensen; A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.

Authors:  D S Samuels; R T Marconi; W M Huang; C F Garon
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

8.  Bacterial genetics by flow cytometry: rapid isolation of Salmonella typhimurium acid-inducible promoters by differential fluorescence induction.

Authors:  R H Valdivia; S Falkow
Journal:  Mol Microbiol       Date:  1996-10       Impact factor: 3.501

9.  Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.

Authors:  D S Samuels; K E Mach; C F Garon
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

10.  Roxithromycin in the treatment of Lyme disease--update and perspectives.

Authors:  R Gasser; I Wendelin; E Reisinger; J Bergloff; B Feigl; I Schafhalter; B Eber; M Grisold; W Klein
Journal:  Infection       Date:  1995       Impact factor: 3.553

View more
  38 in total

1.  Expression of a luxS gene is not required for Borrelia burgdorferi infection of mice via needle inoculation.

Authors:  Anette Hübner; Andrew T Revel; Dena M Nolen; Kayla E Hagman; Michael V Norgard
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Identification of specific chemoattractants and genetic complementation of a Borrelia burgdorferi chemotaxis mutant: flow cytometry-based capillary tube chemotaxis assay.

Authors:  Richard G Bakker; Chunhao Li; Michael R Miller; Cynthia Cunningham; Nyles W Charon
Journal:  Appl Environ Microbiol       Date:  2006-12-15       Impact factor: 4.792

4.  Analysis of the ospC regulatory element controlled by the RpoN-RpoS regulatory pathway in Borrelia burgdorferi.

Authors:  Xiaofeng F Yang; Meghan C Lybecker; Utpal Pal; Sophie M Alani; Jon Blevins; Andrew T Revel; D Scott Samuels; Michael V Norgard
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 6.  Genetic Manipulation of Borrelia Spp.

Authors:  Dan Drecktrah; D Scott Samuels
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

7.  aadA confers streptomycin resistance in Borrelia burgdorferi.

Authors:  Kristi L Frank; Sharyl F Bundle; Michele E Kresge; Christian H Eggers; D Scott Samuels
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

8.  Regulation of expression of the fibronectin-binding protein BBK32 in Borrelia burgdorferi.

Authors:  Ming He; Bethany K Boardman; Dalai Yan; X Frank Yang
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

9.  Role of Borrelia burgdorferi linear plasmid 25 in infection of Ixodes scapularis ticks.

Authors:  Keith O Strother; Aravinda de Silva
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

10.  Use of rpsL as a Counterselectable Marker in Borrelia burgdorferi.

Authors:  Dan Drecktrah; J Miles Douglas; D Scott Samuels
Journal:  Appl Environ Microbiol       Date:  2009-12-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.